Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 2 subunit alpha (EIF2S1), also known as eIF2-alpha, is a central regulator of protein synthesis initiation in eukaryotic cells (UniProt: P05198). It functions as part of the eIF2 heterotrimeric complex, which is responsible for delivering the initiator methionyl-tRNA to the 40S ribosomal subunit (PubMed: 16289705). The activity of EIF2S1 is primarily controlled by its phosphorylation at Serine 51 by a family of four kinases (PERK, PKR, GCN2, and HRI) in response to various cellular stresses, such as endoplasmic reticulum stress, viral infection, and nutrient deprivation (PubMed: 19131336). This phosphorylation event triggers the integrated stress response (ISR), which globally suppresses protein synthesis to conserve energy while selectively promoting the translation of stress-adaptive genes like ATF4 (PubMed: 33384352). Dysregulation of the EIF2S1-mediated ISR is implicated in a wide range of pathologies, including cancer, where it supports tumor survival under harsh conditions, and neurodegenerative diseases like Alzheimer's and Parkinson's, where chronic activation leads to neuronal dysfunction (PubMed: 36719671). Therapeutic strategies targeting this pathway include small molecules like Salubrinal and Sephin1, which inhibit the dephosphorylation of EIF2S1 to prolong the protective stress response, and ISRIB, which reverses the inhibitory effects of EIF2S1 phosphorylation to restore normal translation (Wikipedia; BioCentury).
Inhibition of eIF2-alpha dephosphorylation and modulation of the integrated stress response
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 2 subunit alpha (eIF2-alpha) (EIF2S1).